IBDEI04F ; ; 06-AUG-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 06, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5621,0)
 ;;=V10.02^^48^426^77
 ;;^UTILITY(U,$J,358.3,5621,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5621,1,4,0)
 ;;=4^V10.02
 ;;^UTILITY(U,$J,358.3,5621,1,5,0)
 ;;=5^H/O Oral Cavity/Pharynx Cancer
 ;;^UTILITY(U,$J,358.3,5621,2)
 ;;=^295204
 ;;^UTILITY(U,$J,358.3,5622,0)
 ;;=V10.43^^48^426^78
 ;;^UTILITY(U,$J,358.3,5622,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5622,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,5622,1,5,0)
 ;;=5^H/O Ovarian Cancer
 ;;^UTILITY(U,$J,358.3,5622,2)
 ;;=^295221
 ;;^UTILITY(U,$J,358.3,5623,0)
 ;;=V10.46^^48^426^79
 ;;^UTILITY(U,$J,358.3,5623,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5623,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,5623,1,5,0)
 ;;=5^H/O Prostate Cancer
 ;;^UTILITY(U,$J,358.3,5623,2)
 ;;=^295224
 ;;^UTILITY(U,$J,358.3,5624,0)
 ;;=V10.06^^48^426^80
 ;;^UTILITY(U,$J,358.3,5624,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5624,1,4,0)
 ;;=4^V10.06
 ;;^UTILITY(U,$J,358.3,5624,1,5,0)
 ;;=5^H/O Rectal/Anal Cancer
 ;;^UTILITY(U,$J,358.3,5624,2)
 ;;=^295208
 ;;^UTILITY(U,$J,358.3,5625,0)
 ;;=V10.52^^48^426^81
 ;;^UTILITY(U,$J,358.3,5625,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5625,1,4,0)
 ;;=4^V10.52
 ;;^UTILITY(U,$J,358.3,5625,1,5,0)
 ;;=5^H/O Renal Cancer
 ;;^UTILITY(U,$J,358.3,5625,2)
 ;;=H/o Renal Cancer^295229
 ;;^UTILITY(U,$J,358.3,5626,0)
 ;;=V10.04^^48^426^83
 ;;^UTILITY(U,$J,358.3,5626,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5626,1,4,0)
 ;;=4^V10.04
 ;;^UTILITY(U,$J,358.3,5626,1,5,0)
 ;;=5^H/O Stomach Cancer
 ;;^UTILITY(U,$J,358.3,5626,2)
 ;;=^295206
 ;;^UTILITY(U,$J,358.3,5627,0)
 ;;=V10.47^^48^426^84
 ;;^UTILITY(U,$J,358.3,5627,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5627,1,4,0)
 ;;=4^V10.47
 ;;^UTILITY(U,$J,358.3,5627,1,5,0)
 ;;=5^H/O Testicular Cancer
 ;;^UTILITY(U,$J,358.3,5627,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,5628,0)
 ;;=V10.83^^48^426^82
 ;;^UTILITY(U,$J,358.3,5628,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5628,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,5628,1,5,0)
 ;;=5^H/O Skin Cancer
 ;;^UTILITY(U,$J,358.3,5628,2)
 ;;=H/O Skin Cancer^295241
 ;;^UTILITY(U,$J,358.3,5629,0)
 ;;=285.22^^48^426^20
 ;;^UTILITY(U,$J,358.3,5629,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5629,1,4,0)
 ;;=4^285.22
 ;;^UTILITY(U,$J,358.3,5629,1,5,0)
 ;;=5^Anemia In Cancer
 ;;^UTILITY(U,$J,358.3,5629,2)
 ;;=^321978
 ;;^UTILITY(U,$J,358.3,5630,0)
 ;;=285.21^^48^426^21
 ;;^UTILITY(U,$J,358.3,5630,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5630,1,4,0)
 ;;=4^285.21
 ;;^UTILITY(U,$J,358.3,5630,1,5,0)
 ;;=5^Anemia In Renal Dis
 ;;^UTILITY(U,$J,358.3,5630,2)
 ;;=^321977
 ;;^UTILITY(U,$J,358.3,5631,0)
 ;;=285.29^^48^426^22
 ;;^UTILITY(U,$J,358.3,5631,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5631,1,4,0)
 ;;=4^285.29
 ;;^UTILITY(U,$J,358.3,5631,1,5,0)
 ;;=5^Anemia Of Chronic Dis
 ;;^UTILITY(U,$J,358.3,5631,2)
 ;;=^321979
 ;;^UTILITY(U,$J,358.3,5632,0)
 ;;=284.9^^48^426^24
 ;;^UTILITY(U,$J,358.3,5632,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5632,1,4,0)
 ;;=4^284.9
 ;;^UTILITY(U,$J,358.3,5632,1,5,0)
 ;;=5^Aplastic Anemia Nos
 ;;^UTILITY(U,$J,358.3,5632,2)
 ;;=^7020
 ;;^UTILITY(U,$J,358.3,5633,0)
 ;;=282.61^^48^426^89
 ;;^UTILITY(U,$J,358.3,5633,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5633,1,4,0)
 ;;=4^282.61
 ;;^UTILITY(U,$J,358.3,5633,1,5,0)
 ;;=5^Hemoglobin S Disease
 ;;^UTILITY(U,$J,358.3,5633,2)
 ;;=^267981
 ;;^UTILITY(U,$J,358.3,5634,0)
 ;;=282.7^^48^426^88
 ;;^UTILITY(U,$J,358.3,5634,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5634,1,4,0)
 ;;=4^282.7
 ;;^UTILITY(U,$J,358.3,5634,1,5,0)
 ;;=5^Hemoglobin C Disease
 ;;^UTILITY(U,$J,358.3,5634,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,5635,0)
 ;;=283.9^^48^426^91
 ;;^UTILITY(U,$J,358.3,5635,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5635,1,4,0)
 ;;=4^283.9
 ;;^UTILITY(U,$J,358.3,5635,1,5,0)
 ;;=5^Hemolytic Anemia , Acquired
 ;;^UTILITY(U,$J,358.3,5635,2)
 ;;=^7071
 ;;^UTILITY(U,$J,358.3,5636,0)
 ;;=283.0^^48^426^92
 ;;^UTILITY(U,$J,358.3,5636,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5636,1,4,0)
 ;;=4^283.0
 ;;^UTILITY(U,$J,358.3,5636,1,5,0)
 ;;=5^Hemolytic Anemia, Autoimmune
 ;;^UTILITY(U,$J,358.3,5636,2)
 ;;=^7079
 ;;^UTILITY(U,$J,358.3,5637,0)
 ;;=282.9^^48^426^90
 ;;^UTILITY(U,$J,358.3,5637,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5637,1,4,0)
 ;;=4^282.9
 ;;^UTILITY(U,$J,358.3,5637,1,5,0)
 ;;=5^Hemolytic Anem, Heredit
 ;;^UTILITY(U,$J,358.3,5637,2)
 ;;=^56578
 ;;^UTILITY(U,$J,358.3,5638,0)
 ;;=283.19^^48^426^93
 ;;^UTILITY(U,$J,358.3,5638,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5638,1,4,0)
 ;;=4^283.19
 ;;^UTILITY(U,$J,358.3,5638,1,5,0)
 ;;=5^Hemolytic Anemia, Microang
 ;;^UTILITY(U,$J,358.3,5638,2)
 ;;=^293664
 ;;^UTILITY(U,$J,358.3,5639,0)
 ;;=280.9^^48^426^97
 ;;^UTILITY(U,$J,358.3,5639,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5639,1,4,0)
 ;;=4^280.9
 ;;^UTILITY(U,$J,358.3,5639,1,5,0)
 ;;=5^Iron Defic Anemia(Unspecified)
 ;;^UTILITY(U,$J,358.3,5639,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,5640,0)
 ;;=285.1^^48^426^95
 ;;^UTILITY(U,$J,358.3,5640,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5640,1,4,0)
 ;;=4^285.1
 ;;^UTILITY(U,$J,358.3,5640,1,5,0)
 ;;=5^Iron Defic Anemia Due To Acute Blood Loss
 ;;^UTILITY(U,$J,358.3,5640,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,5641,0)
 ;;=280.0^^48^426^96
 ;;^UTILITY(U,$J,358.3,5641,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5641,1,4,0)
 ;;=4^280.0
 ;;^UTILITY(U,$J,358.3,5641,1,5,0)
 ;;=5^Iron Defic Anemia Due To Chronic Blood Loss
 ;;^UTILITY(U,$J,358.3,5641,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,5642,0)
 ;;=281.9^^48^426^117
 ;;^UTILITY(U,$J,358.3,5642,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5642,1,4,0)
 ;;=4^281.9
 ;;^UTILITY(U,$J,358.3,5642,1,5,0)
 ;;=5^Nutritional Anemia
 ;;^UTILITY(U,$J,358.3,5642,2)
 ;;=^123801
 ;;^UTILITY(U,$J,358.3,5643,0)
 ;;=281.0^^48^426^140
 ;;^UTILITY(U,$J,358.3,5643,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5643,1,4,0)
 ;;=4^281.0
 ;;^UTILITY(U,$J,358.3,5643,1,5,0)
 ;;=5^Vit B12 Deficiency (Pernicious Anemia)
 ;;^UTILITY(U,$J,358.3,5643,2)
 ;;=^7161
 ;;^UTILITY(U,$J,358.3,5644,0)
 ;;=282.60^^48^426^124
 ;;^UTILITY(U,$J,358.3,5644,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5644,1,4,0)
 ;;=4^282.60
 ;;^UTILITY(U,$J,358.3,5644,1,5,0)
 ;;=5^Sickle-Cell Anemia
 ;;^UTILITY(U,$J,358.3,5644,2)
 ;;=^7188
 ;;^UTILITY(U,$J,358.3,5645,0)
 ;;=282.62^^48^426^125
 ;;^UTILITY(U,$J,358.3,5645,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5645,1,4,0)
 ;;=4^282.62
 ;;^UTILITY(U,$J,358.3,5645,1,5,0)
 ;;=5^Sickle-Cell With Crisis
 ;;^UTILITY(U,$J,358.3,5645,2)
 ;;=^267982
 ;;^UTILITY(U,$J,358.3,5646,0)
 ;;=281.1^^48^426^141
 ;;^UTILITY(U,$J,358.3,5646,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5646,1,4,0)
 ;;=4^281.1
 ;;^UTILITY(U,$J,358.3,5646,1,5,0)
 ;;=5^Vit B12 Deficiency(Dietary)
 ;;^UTILITY(U,$J,358.3,5646,2)
 ;;=^267974
 ;;^UTILITY(U,$J,358.3,5647,0)
 ;;=286.7^^48^426^64
 ;;^UTILITY(U,$J,358.3,5647,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5647,1,4,0)
 ;;=4^286.7
 ;;^UTILITY(U,$J,358.3,5647,1,5,0)
 ;;=5^Coagulation Defect(Any),Acquired
 ;;^UTILITY(U,$J,358.3,5647,2)
 ;;=^2235
 ;;^UTILITY(U,$J,358.3,5648,0)
 ;;=289.9^^48^426^137
 ;;^UTILITY(U,$J,358.3,5648,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5648,1,4,0)
 ;;=4^289.9
 ;;^UTILITY(U,$J,358.3,5648,1,5,0)
 ;;=5^Thrombocytosis, Essential
 ;;^UTILITY(U,$J,358.3,5648,2)
 ;;=^55344
 ;;^UTILITY(U,$J,358.3,5649,0)
 ;;=451.9^^48^426^138
 ;;^UTILITY(U,$J,358.3,5649,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5649,1,4,0)
 ;;=4^451.9
 ;;^UTILITY(U,$J,358.3,5649,1,5,0)
 ;;=5^Thrombophlebitis 
 ;;^UTILITY(U,$J,358.3,5649,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,5650,0)
 ;;=446.6^^48^426^139
 ;;^UTILITY(U,$J,358.3,5650,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5650,1,4,0)
 ;;=4^446.6
 ;;^UTILITY(U,$J,358.3,5650,1,5,0)
 ;;=5^Thrombotic Thrombocytopenic Purpura(TTP)
 ;;^UTILITY(U,$J,358.3,5650,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,5651,0)
 ;;=286.4^^48^426^143
 ;;^UTILITY(U,$J,358.3,5651,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5651,1,4,0)
 ;;=4^286.4
 ;;^UTILITY(U,$J,358.3,5651,1,5,0)
 ;;=5^Von Willebrand's Disease
 ;;^UTILITY(U,$J,358.3,5651,2)
 ;;=^127267
 ;;^UTILITY(U,$J,358.3,5652,0)
 ;;=204.00^^48^426^17
 ;;^UTILITY(U,$J,358.3,5652,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5652,1,4,0)
 ;;=4^204.00
 ;;^UTILITY(U,$J,358.3,5652,1,5,0)
 ;;=5^All, W/O Remission
 ;;^UTILITY(U,$J,358.3,5652,2)
 ;;=^267521
 ;;^UTILITY(U,$J,358.3,5653,0)
 ;;=204.01^^48^426^16
 ;;^UTILITY(U,$J,358.3,5653,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5653,1,4,0)
 ;;=4^204.01
 ;;^UTILITY(U,$J,358.3,5653,1,5,0)
 ;;=5^All, In Remission
 ;;^UTILITY(U,$J,358.3,5653,2)
 ;;=^267522
 ;;^UTILITY(U,$J,358.3,5654,0)
 ;;=204.10^^48^426^61
 ;;^UTILITY(U,$J,358.3,5654,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5654,1,4,0)
 ;;=4^204.10
 ;;^UTILITY(U,$J,358.3,5654,1,5,0)
 ;;=5^Cll, W/O Remission
 ;;^UTILITY(U,$J,358.3,5654,2)
 ;;=^267523
 ;;^UTILITY(U,$J,358.3,5655,0)
 ;;=204.11^^48^426^60
 ;;^UTILITY(U,$J,358.3,5655,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5655,1,4,0)
 ;;=4^204.11
 ;;^UTILITY(U,$J,358.3,5655,1,5,0)
 ;;=5^Cll, In Remission
 ;;^UTILITY(U,$J,358.3,5655,2)
 ;;=^267524
 ;;^UTILITY(U,$J,358.3,5656,0)
 ;;=202.41^^48^426^87
 ;;^UTILITY(U,$J,358.3,5656,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5656,1,4,0)
 ;;=4^202.41
 ;;^UTILITY(U,$J,358.3,5656,1,5,0)
 ;;=5^Hairy Cell Leukemia,Unspec Site
 ;;^UTILITY(U,$J,358.3,5656,2)
 ;;=^267472
 ;;^UTILITY(U,$J,358.3,5657,0)
 ;;=201.90^^48^426^94
 ;;^UTILITY(U,$J,358.3,5657,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5657,1,4,0)
 ;;=4^201.90
 ;;^UTILITY(U,$J,358.3,5657,1,5,0)
 ;;=5^Hodgkin's Lymphoma,Unspec Type & Site
 ;;^UTILITY(U,$J,358.3,5657,2)
 ;;=^267430
 ;;^UTILITY(U,$J,358.3,5658,0)
 ;;=785.6^^48^426^101
 ;;^UTILITY(U,$J,358.3,5658,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5658,1,4,0)
 ;;=4^785.6
 ;;^UTILITY(U,$J,358.3,5658,1,5,0)
 ;;=5^Lymphadenopathy
